Cyclacel Pharmaceuticals, Inc. (CYCC)
NASDAQ: CYCC · Real-Time Price · USD
8.21
-1.60 (-16.31%)
At close: Aug 5, 2025, 4:00 PM
8.12
-0.09 (-1.10%)
After-hours: Aug 5, 2025, 7:59 PM EDT
MorphoSys AG Market Cap
Cyclacel Pharmaceuticals has a market cap or net worth of $13.00 million as of August 5, 2025. Its market cap has increased by 419.80% in one year.
Market Cap
13.00M
Enterprise Value
9.56M
1-Year Change
419.80%
Ranking
Category
Stock Price
$8.21
Market Cap Chart
Since May 16, 2006, Cyclacel Pharmaceuticals's market cap has decreased from $90.74M to $13.00M, a decrease of -85.67%. That is a compound annual growth rate of -9.61%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 4, 2025 | 15.54M | 557.33% |
| Dec 31, 2024 | 2.36M | -13.14% |
| Dec 29, 2023 | 2.72M | -67.46% |
| Dec 30, 2022 | 8.36M | -78.44% |
| Dec 31, 2021 | 38.79M | 2.12% |
| Dec 31, 2020 | 37.98M | 230.84% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 684.07B |
| Johnson & Johnson | 409.42B |
| AbbVie | 348.45B |
| AstraZeneca | 229.32B |
| Abbott Laboratories | 227.39B |
| Novartis AG | 226.38B |
| UnitedHealth Group | 221.80B |
| Novo Nordisk | 215.34B |